The Polish pharmaceutical market value (in gross retail prices) rose by 3.7% y/y to around PLN 22.3bn (EUR 5.4bn) in 2011. However, medicine sales declined this year due to the new controversial reimbursement act enforced in January.
According to market data, pharmaceutical sales dropped by approximately 4% y/y between Jan-Sep 2012. The decline was noticeable both on the retail level and also in medicine output. Calculations based on official statistics shows that the pharmaceuticals sold production...
Keep on reading: New pharmaceutical legislation causes ill effect in Poland
Keep on reading: New pharmaceutical legislation causes ill effect in Poland